Canonical: https://ownershiptrace.com/13f/companies/1117

# Who owns Immunocore Holdings plc (IMCR)? Elite investor 13F holders

5 tracked elite investors reported holding Immunocore Holdings plc as of 2026-06-30, including Caligan Partners, D.E. Shaw, Renaissance Technologies LLC, Bridgewater Associates, Oaktree Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. It also develops oncology programs, including…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Caligan Partners](https://ownershiptrace.com/13f/investors/125) | IMMUNOCORE HLDGS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 43856815.00 USD | 1381317.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1727492/0001420506-26-001809-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | IMMUNOCORE HLDGS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12862433.00 USD | 405116.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | IMMUNOCORE HLDGS PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 3251200.00 USD | 102400.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | IMMUNOCORE HLDGS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1165447.00 USD | 36707.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [Oaktree Capital Management](https://ownershiptrace.com/13f/investors/44) | IMMUNOCORE HOLDINGS PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 766360.00 USD | 833000.000000 | Principal | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/949509/0000949509-26-000005-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)